Gupta A, Valecha B, Gupta N. Butorphanol in epidural: Could this be the breakthrough solution for safe and effective labor analgesia that we've been waiting for? World J Clin Cases 2024; 12(32): 6566-6569 [PMID: 39554889 DOI: 10.12998/wjcc.v12.i32.6566]
Corresponding Author of This Article
Nishkarsh Gupta, MD, Professor, Department of Onco-Anesthesiology and Palliative Medicine, All India Institute of Medical Sciences, Room No 139 FF IRCH AIIMS, New Delhi 110029, India. drnishkarsh@rediffmail.com
Research Domain of This Article
Anesthesiology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Nov 16, 2024; 12(32): 6566-6569 Published online Nov 16, 2024. doi: 10.12998/wjcc.v12.i32.6566
Butorphanol in epidural: Could this be the breakthrough solution for safe and effective labor analgesia that we've been waiting for?
Anju Gupta, Brinda Valecha, Nishkarsh Gupta
Anju Gupta, Department of Anesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi 110076, Delhi, India
Brinda Valecha, Department of Anaesthesia, All India Institute of Medical Sciences, New Delhi 110029, India
Nishkarsh Gupta, Department of Onco-Anesthesiology and Palliative Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
Author contributions: Gupta A analyzed the paper and wrote the first draft. Valecha B wrote the first draft along with Gupta N; All authors analysed the draft and finalzed the content.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Nishkarsh Gupta, MD, Professor, Department of Onco-Anesthesiology and Palliative Medicine, All India Institute of Medical Sciences, Room No 139 FF IRCH AIIMS, New Delhi 110029, India. drnishkarsh@rediffmail.com
Received: March 10, 2024 Revised: August 10, 2024 Accepted: September 11, 2024 Published online: November 16, 2024 Processing time: 197 Days and 11.3 Hours
Abstract
The authors have conducted a comprehensive investigation into the safety and effectiveness of butorphanol for epidural analgesia during labor. Their critical analysis of the paper and discussion of the technique's advantages and disadvantages provide a thorough understanding of the topic.
Core Tip: Labor pain is one of the most agonizing pains a woman experiences, which can affect both the mother and the fetus physiologically. Among the various methods of labor analgesia, pharmacological interventions play a crucial role. Of all these practices, epidural analgesia has been the most effective and thus widely accepted technique. No study has comprehensively examined the effectiveness and safety of using epidural butorphanol as an analgesic during labor. The authors have investigated the safety and effectiveness of butorphanol for epidural analgesia during labor.
